Dimensional Fund Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Dimensional Fund Advisors's AXSM Position: Q3 2026 in Review
Dimensional Fund Advisors reduced its Axsome Therapeutics (AXSM) stake by 18% in Q3 2026, selling an estimated $886K and leaving 18,595 shares worth $3.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2594.
Dimensional Fund Advisors first reported a position in AXSM in Q1 2025 and has held it in 7 quarters since. The position peaked at $5.55M in Q2 2026. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Dimensional Fund Advisors held 18,595 shares of Axsome Therapeutics worth $3.43M as of Q3 2026.
- Dimensional Fund Advisors sold 4,075 Axsome Therapeutics shares in Q3 2026, an estimated $886K.
- Axsome Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2594 holding.
- Dimensional Fund Advisors first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 7 quarters since.
- Dimensional Fund Advisors's Axsome Therapeutics position peaked at $5.55M in Q2 2026.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.